Zimbabwe signs reference dependence MoU with Egypt’s EDA

Reuters Images

Under the MoU, both authorities will organize capacity-building and technical support activities

Staff Writer, Arab Finance

May 15, 2023

PHOTO

The Egyptian Drug Authority (EDA) has signed a memorandum of understanding (MoU) with the Medicines Control Authority of Zimbabwe (MCAZ) to allow the latter to rely on the EDA’s procedures in the field of pharmaceuticals registration as a reference point, the EDA stated on May 13th.

Under the MoU, both authorities will organize capacity-building and technical support activities, along with allowing the MCAZ to register its locally manufactured pharmaceuticals at the EDA to be traded in Zimbabwe.

This would facilitate Egyptian pharmaceuticals’ access to the Zimbabwean market, thus, to the entire African continent.

The deal comes within the framework of the EDA’s plans to cooperate with other regulatory authorities to enter the African markets.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.